CEFDINIR
- UNII: CI0FAO63WC
- Formula: C14H13N5O5S2
- Preferred Substance Name: CEFDINIR
- InChIKey: RTXOFQZKPXMALH-GHXIOONMSA-N
- 91832-40-5
- (-)-(6R,7R)-7-(2-(2-AMINO-4-THIAZOLYL)GLYOXYLAMIDO)-8-OXO-3-VINYL-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 72-(Z)-OXIME
- (6R,7R)-7-(((2Z)-(2-AMINO-4-THIAZOLYL)(HYDROXYIMINO)ACETYL)AMINO)-3-ETHENYL-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID
- 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7-(((2-AMINO-4-THIAZOLYL) (HYDROXYIMINO)ACETYL)AMINO)-3-ETHENYL-8-OXO-, (6R-(6.ALPHA.,7.BETA.(Z)))-
- BMY-28488
- CEFDINIR [INN]
- CEFDINIR [JAN]
- CEFDINIR [MART.]
- CEFDINIR [MI]
- CEFDINIR [ORANGE BOOK]
- CEFDINIR [USAN]
- CEFDINIR [USP MONOGRAPH]
- CEFDINIR [USP-RS]
- CEFDINIR [VANDF]
- CEFDINIR [WHO-DD]
- CEFDINIR ANHYDROUS
- CEFZON
- CI-983
- FK 482
- FK-482
- NSC-758926
- OMNICEF
- SYN-7-(2-(2-AMINO-4-THIAZOLYL)-2-HYDROXYIMINOACETAMIDO)-3-VINYL-3-CEPHEM-4-CARBOXYLIC ACID
About, Contact Us, Copyright, Privacy, Accessibility
U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002
U.S. Food and Drug Administration, Health & Human Services
Powered by
